Experience Model

CDX Models

Medicilon’s CDX Models provide a highly reliable and reproducible platform for evaluating anti-cancer therapies.

Experience Model

PDX Models

Highly predictive, clinically relevant platform that preserves tumor heterogeneity, enabling more accurate evaluation of drug efficacy and personalized cancer therapy.

Experience Model

GEM Models

Genetically engineered mouse (GEM) models are widely used and have proved to be a powerful tool to improve drug discovery processes.

Experience Model

Humanized Models

Offer a clinically relevant platform to study human immune-tumor interactions, accelerating the development of effective and personalized cancer therapies.

Experience Model

Syngeneic Models

Syngeneic tumor models are highly effective in preclinical research for studying cancer biology, assessing therapeutic strategies, and understanding immune responses within a controlled genetic environment.

Experience Model

Orthotopic Models

Enhance cancer research by replicating tumor environments, improving drug assessment, and boosting translational accuracy.

Experience Model

Tumor resistance models

Resistant models are important preclinical research tools for drug resistance mechanism study and development of novel therapeutic drugs or strategies.